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Abstract By use of the signal sequence trap method, we isolated 
a cDNA encoding a novel aspartic protease-like protein from the 
mouse kidney, and termed it 'kidney-derived aspartic protease-
like protein (KAP).' The protein, a 419-amino-acid polypeptide 
with a 16-amino-acid signal sequence, had 47% identity with 
mouse cathepsin D, and its overall structure was closely related 
to known aspartic proteases. Northern blot analysis revealed that 
KAP mRNA is expressed at the highest level in the kidney, at a 
moderate level in the lung, and at low levels in the spleen and 
adipose tissue. In situ hybridization analysis demonstrated that 
the mRNA is expressed abundantly in the proximal straight 
tubule and slightly, but significantly, in the proximal convoluted 
tubule in the kidney. This intra-renal distribution differs 
distinctly from those of previously reported proteases such as 
cathepsins B, D, and H. 
Key words: Aspartic protease; Cathepsin; Signal sequence 
trap; (Mouse kidney) 
1. Introduction 
Aspartic proteases (EC 3.4.23) are a group of endopepti-
dase of the pepsin family that share the same catalytic appa-
ratus and usually function in acidic pH [1]. The best known 
sources of mammalian aspartic proteases are stomach (for 
gastric aspartic proteases; pepsin A, gastricsin, and chymo-
sin), kidney (for renin), lysosome (for cathepsin D), endoplas-
mic reticulum (for cathepsin E). The functions of these en-
zymes include the digestion of proteins such as casein and clot 
milk (for gastric aspartic proteases), the biosynthesis of angio-
tensin I from angiotensinogen (for renin), and the degradation 
of intracellular and endocytosed proteins (for cathepsin D) [2]. 
The physiologic function of cathepsin E is currently unknown. 
All these aspartic proteases are synthesized as proenzymes (or 
zymogens) and are proteolytically activated to mature pro-
teases [1,2]. 
To identify novel proteins that are involved in the physio-
logic functions of the kidney, we have tried to isolate cDNAs 
for novel proteins from the mouse kidney by use of the signal 
sequence trap method [3]. This method has enabled us to 
molecularly clone novel secretory proteins and type-I trans-
membrane proteins [4]. We here report molecular cloning of a 
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mouse c D N A encoding 'kidney-derived aspartic protease-like 
protein (KAP) ' . 
2. Materials and methods 
2.1. Tissue preparation and RNA extraction 
The whole kidney and other tissues were obtained from 8-week-old 
male BALB/c mice. Tissues were frozen in liquid nitrogen and stored 
at — 84°C until use. Total RNA extraction was carried out as de-
scribed [5]. Poly(A)+ RNA was purified using PolyATtract (Promega, 
Madison, WI). 
2.2. Signal sequence trap 
Signal sequence trap was performed as described [3,4] with slight 
modifications. Two micrograms of poly(A)+ RNA from the mouse 
kidney was reverse transcribed by random hexamer priming using 
SuperScript II reverse transcriptase (Gibco BRL, Grand Island, 
NY), and deoxyadenosine (dA) tails were added at the 3'-end of the 
first strand cDNA. The second strand was synthesized with a specific 
primer containing polydeoxythimidine (dT) and EcoKl restriction 
3') and ligated with a SacI adaptor. The cDNA fragments of 300-
700 bp in size were isolated by a 1.6% agarose gel electrophoresis and 
subjected to polymerase chain reaction (PCR). The reaction profile 
was as follows: denaturation at 94°C for 30 s, annealing at 49°C for 
2 min, and extension at 72°C for 3 min for 25 cycles. The amplified 
fragments were digested with .EcoRI and Sacl, size-fractionated by 
agarose gel electrophoresis, and subcloned into the EcoRI and Sacl 
sites of the pcDL-SRa-Tac(3') vector [6,7]. The expression plasmid 
library thus obtained was transfected to COS-7 cells by the lipofection 
method (Transfectam, Sepracor, Marlborough, MA), and the fusion 
proteins expressed on the cell surface were microscopically detected by 
immunostaining with anti-Tac antibody [8]. 
2.3. Rapid amplification of 3'-cDNA ends (3'-RACE) 
The 3'-RACE experiment was performed using Marathon cDNA 
amplification kit (Clontech Inc., Mountain View, CA). One micro-
gram of poly(A)+ RNA from the mouse kidney was reverse tran-
scribed by oligo (dT)i5 priming, using SuperScript II reverse transcrip-
tase. After synthesis of the second-strand cDNA by the method of 
Gubler and Hoffman [9] and ligation with the Marathon cDNA adap-
tor, PCR was carried out using a 5'-gene-specific primer (5'-
CATCTTGGCCCAGCTCTAGTCC-3') and an adaptor primer (5'-
CCATCCTAATACGACTCACTATAGGGC-3'). Aliquot of the re-
action was further subjected to PCR using a downstream 5'-gene-
specific primer (5'-ATCCGTGTCCCTCTTCAACG-3') and a nested 
adaptor primer (5'-ACTCACTATAGGGCTCGAGCGGC-3'). The 
3'-RACE product was subcloned into the pCR II vector (Invitrogen 
Corp., San Diego, CA) for sequencing. 
2.4. DNA sequencing 
Nucleotide sequences were determined by the dideoxy chain-termi-
nation method using Dye Terminator Cycle Sequencing Kit, FS (Ap-
plied Biosystems Inc., Foster City, CA). All DNA sequences were 
confirmed by reading both DNA strands. 
2.5. Northern blot analysis 
Northern blot analysis was performed as described [10] with the 
32P-labeled EcoRl-Sacl restriction fragment (nucleotide —171 to 
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+201) of mouse KAP cDNA as a probe. The blot was used to expose 
BAS-III imaging plate (Fuji, Kanagawa, Japan) for 20 h. 
2.6. In situ hybridization analysis 
Sense and antisense 35S-CTP-labeled complementary RNA (cRNA) 
were synthesized from the cloned mouse KAP cDNA fragment (nu-
cleotide +70 to +1123), alkaline hydrolyzed to approximately 150 bp 
products, and used as probes. In situ hybridization analysis was per-
formed as previously described [11]. In brief, 10 μpiι cryosections from 
8-week-old BALB/c mouse kidneys were mounted on poly-L-lysine-
coated slides and stored at —84°C. After fixation in phosphate-buf-
fered saline with 4% paraformaldehyde and acetylation in 0.1 M 
triethanolamine with 0.25% acetic anhydride, hybridization was per-
formed at 57°C for 8 h by adding 35S-labeled cRNA probe at a final 
concentration of 1X108 cpm/ml in 50% formamide containing 
2XSSC (1XSSC is 150 mM NaCl, 15 mM sodium citrate), 10 mM 
Tris-HCl (pH 7.4), 100 mM dithiothreitol, lXDenhardt's solution, 
0.2% sodium dodecyl sulfate, 10% dextran sulfate, 250 μ&Ίη1 yeast 
tRNA, and 500 μg/ml salmon sperm DNA. Slides were washed and 
treated with 20 μg/ml RNase A, washed in 0.1XSSC at 60°C, and 
dehydrated in graded ethanols containing 0.3 M ammonium acetate, 
and dried. Slides were apposed to Hyperfilm ß-max film (Amersham 
International, Buckinghamshire, UK) for 13 h, or dipped into auto-
radiographic emulsion (NTB-2, Kodak, Rochester, NY), exposed at 
4°C for 4 weeks, and counterstained with hematoxylin and eosin. 
a putative 16-amino-acid signal sequence, as predicted by von 
Heijne's algorithm [12]. 
3.2. Isolation and sequence analysis of a full-length mouse KAP 
cDNA 
To obtain the full-length cDNA clone, the 3'-RACE experi-
ment was performed. A 1.2 kb fragment was obtained and 
sequenced. Nucleotide and deduced amino acid sequences of 
the full-length cDNA revealed that the 1479 bp nucleotide 
sequence includes the longest open reading frame, predicting 
a protein of 419-amino-acid residues with a relative molecular 
mass of 45.5 kDa (Fig. 1). The 5'-untranslated region con-
tained a short tandem dinucleotide repeat ((CA)24). In the 3'-
untranslated region, a potential polyadenylation signal [13] 
occurred 42 bp downstream of the translation termination 
codon. 
The predicted protein possessed two conserved active sites 
of aspartic proteases [1,2]. Five potential N-linked glycosyla-
tion motifs were found, some of which may be glycosylated, 
mannose-6-phosphorylated, and may serve as lysosomal tar-
geting signals [14,15]. 
3. Results and discussion 
3.1 Screening of mouse kidney cDNA library by signal 
sequence trap 
Four thousand plasmid clones were screened, and 22 posi-
tive clones were obtained, all of which were subjected to se-
quencing. A single clone of 372 bp in size (E3A5, Fig. 1 thick 
box) contained a putative translation initiation codon pre-
ceded by an in-frame termination codon 12 bp upstream to 
it. The cDNA fragment encoded a 67-amino-acid peptide with 
3.3. Sequence comparison among mammalian aspartic 
proteases 
Fig. 2 shows amino acid sequence comparison of KAP with 
six known mammalian aspartic proteases. Mouse KAP was 
47%, 46%, 42%, 41%, 39%, 39% identical to mouse cathepsin 
D, human cathepsin E, mouse renal renin, human pepsin A, 
human gastricsin, and bovine chymosin, respectively (Fig. 2). 
The homology was observed throughout the length of the 
molecules, especially around two active site aspartic acid res-
idues. All 7 cysteine residues of KAP, except for the one in the 
GCCCTGCTACTGAAGGACCTCACACACACACACACACACACACACACACAC 
ACACACACATACACACACGTCACTTCTGTGTTCCAGTAGGTGGTGGGGCGTGAACAGGGTGGAGTCTCAAGGGGAAGAAAAGGGCCACAGGACATCTTGGCCCAGCTCTAGTCCCCAGAG 
ATGTCGCCACTACTGCTGCTGCTGCTGTGCCTGCTGCTGGGGAATTTGGAGCCTGAGGAGGCCAAACTGATCCGTGTCCCTCTTCAACGAATCCACCTTGGACACAGAATCTTAAACCCA 
P E E A K L I R V P L Q . R I H L G H R I L N P N L I E 
CTGAATGGATGGGAACAGCTGGCAGAGCTTTCTAGGACCTCCACCTCTGGTGGCAACCCCTCCTTTGTGCCTCTCTCCAAGrTCATGAACACCCAGTATTTTGGAACTATTGGTTTGGGA 
ACGCCTCCTCAGAATTTCACCGTTGTCTTTGACACGGGTTCTTCCAACTTGTGGGTTCCGTCCACGAGATGTCATTTCTTCAGTTTGGCATGCTGGTTTCACCATCGCTTTAATCCCAAG 
T P P Q N F T V V F D T G S S N L W V P S T R C H F F S L A C W F H H R F H P K 
A · · · · · · · · 
GCCTCCAGCTCCTTCAGGCCCAATGGGACCAAGTTTGCCATTCAGTATGGGACCGGGCGGCTGAGCGGAATCCTGAGCCAGGACAATCTGACTATCGGGGGGATCCACGATGCTTTTGTG 
A S S S F R P N G T K F A I Q Y G T G R L S G I L S Q . D N L T I G G I H D A F V 
A A 
ACATTTGGAGAGGCTCTGTGGGAGCCCAGCCTGATCTTTGCTTTAGCCCACTTTGATGGGATCCTGGGCCTCGGCTTCCCCACTCTGGCTGTGGGCGGAGTTCAGCCTCCGCTGGATGCG 
T F G E A L W E P S L I F A L A H F D G I L G L G F P T L A V G G V Q P P L D A 
ATGGTGGAGCAAGGGCTGCTGGAGAAACCCGTCTTCTCCTTTTACCTCAACAGGGATTCTGAAGGGTCTGATGGGGGAGAGCTGGTCCTAGGGGGCTCAGACCCCGCTCACTACGTACCT 
M V E Q G L L E K P V F S F Y L N R D S E G S D G G E L V L G G S D P A H Y V P 
CCCCTCACCTTCATACCAGTCACCATCCCTGCCTACTGGCAGGTCCACATGGAGAGTGTGAAGGTCGGCACAGGGCTGAGCCTCTGTGCCCAGGGCTGCAGTGCCATCCTAGACACAGGC 
P L T F I P V T I P A Y W Q . V H M E S V K V G T G L S L C A Q G C S A I L D T G 
ACATCCCTCATCACAGGACCTAGTGAGGAGATCCGGGCCTTGAATAAAGCCATTGGGGGATATCCCTTCCTGAATGGGCAGTACTTCATTCAGTGTTCCAAGACGCCAACGCTTCCCCCT 
T S L I T G P S E E I R A L N K A I G G Y P F L N G Q Y F I Q C S K T P T L P P 
GTCTCCTTCCACCTTGGTGGAGTCTGGTTTAACCTCACAGGCCAGGACTATGTCATCAAGATTCTTCAGAGCGATGTTGGCCTCTGCCTGTTGGGCTTCCAAGCCTTGGATATCCCCAAG 
V S F H L G G V W F N L T G Q D Y V I K I L Q S D V G L C L L G F Q A L D I P K 
A 
CCTGCGGGACCCCTCTGGATCCTTGGGGACGTCTTTTTGGGGCCCTATGTGGCTGTCTTTGACCGTGGGGACAAAAACGTCGGCCCGCGCGTGGGACTGGCGCGTGCTCAGTCTCGTTCA 
P A G P L W I L G D V F L G P Y V A V F D R G D K N V G P R V G L A R A Q S R S 
ACAGACCGGGCAGAAAGAAGGACTACGCAGGCGCAGTTCTTCAAAAGACGCCCTGGTTAGGGTACAAGCTCACCGGGCCACAGCAGCTATGCTTCTTTCCAATTAAAC 
T D R A E R R T T Q A Q F F K R R P G * 
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Fig. 1. Nucleotide and deduced amino acid sequences of mouse kidney-derived aspartic protease-like protein (KAP) cDNA. The 372 bp cDNA 
fragment (clone E3A5) obtained by the signal sequence trap method is indicated by thick box. Putative signal sequence is indicated by thin box. 
Two primer sequences used for 3'-RACE are indicated by arrows. Nucleotides and amino acids are numbered sequentially from the translation 
initiation site. The translation initiation codon is preceded by an in-frame termination codon (TAG, thin underline), and the termination codon 
is marked by an asterisk. A short tandem dinucleotide repeat ((CA)24) is marked by a thick underline. Potential polyadenylation site (AT-
TAAA) is marked by double underline. Conserved amino acid residues around two active site aspartic acid residues are indicated by dots. Po-
tential N-glycosylation sites are marked by triangles. 
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-WEQLAELSRTSTS-GGNPSFVPLSKFMNTQYFGTIGLGTPPQNF1 W F P T G S E NLWVPSTRCH KAP - m s p l l l l l l c l l l g n l E P E E A K L I R V P L Q R I H L G H R I L N P L N G -
CATD m k t p g v l l l i l g l l a s s s f a IIRIPLKKFTSIRRTMTEVGGSVEDL-
CATE raktllllllvllelgea QGSLHRVPiÄRHPSLKJfX£RARSerSEFK«SHKLDiHQFTESCSMDO.SAKEP-
REN1 m d r r r m p l w a l l l l w s p c t f s l p t r t A T F E R I P i K K i f P S V R E I i E B i ! G V D « r j ! I , S A E f i G r a , T K R P S L T N L T S P W LTNYLNTQYYGEI 
PEPA m k w l l l l g l v a l s e c IM3rjfVPiIRKKSiRfir i ,SBJ?GiLKDFiKXHWI,i iPARKYFPÖKBAPTLVDEQPLENYLDMEYFGTIGIGTPAQDFT|WFDTGSS|NLWVPSVYCS 
PEPC m k w m v v v l v a l q l l e a AWKVPLKKFKSIRETMKEKGLLGEFLRTHKYDPAWKYRFGDLSVTYEP-
CHYM m r c l v v l l a v f a l s q g TEITRIPLYKGKSLRKALKEHGLLEDFLQKQQYGISSKYSGFGEVASVP — 
IIÄGPITKYSMOSSPKTTEPVSELLKNYLPAQYYGDIGIGTPPQCFT WFDTGSE NLWVPSIHCK 
-LINYLPMEYFGTISIGSPPQNFT VIFPTGSS HLWVPSVYCT 
GIGTPPQTFK VIFPTGSJ NLWVPSTKCS 
GTPAQPFTW D GSS NLW
—MAYMPAAYFGEISIGTPPQNFIVLFPTGSE NLWVPSVYCQ 
-LTNYLPSQYFGKIYLGTPPQEFIIVLFPTGSSIPFWVPSIYCK 
KAP FFSLACWFHHRFNPKASSSFRPNGTKFAIQYGTGRLSGILSQPNLTI GeiHDAFVTFGEALWEPSLIFALAHFDGILGLGFPTLAVGGVO.PPLPAMVEO.GLLEKPVFSFYL 
CATD IL·DIACWVHHKYNSDKSSTYVKHGTSFDIHYGSGSL·SGYL·SODTVSVPCKSDOSKARGIKVEKOIFGEATKOPGIVFVAAKFDGIL·GMGYPHISVNHVL·PVFDNL·MOOKL·VDKNIFSFYL· 
CATE S — P A C K T H S R F Q P S Q S S T Y S Q P G Q S F S I Q Y G T G S L S G I I G A P Q V S V EGLTWGQQFGESVTEPGQTFVDAEFDGILGLGYPSLAVGGVTPVFDNMMAQNLVDLPMFSVYM 
R E N l RLYLACGIHSLYESSDSSSYMENGSDFTIHYGSGRVKGFLSQDSVTV GGITVT-QTFGEVTELPLIPFMLAKFDGVLGMGFPAQAVGGVTPVFDHII,SO.GVLKEEVFSVYY 
PEPA S—LACTNHNRFNPEDSSTYQSTSETVSITYGTGSMTGILGYDTVQV GGISPTNQIFGLSETEPGSFLYYAPFPGILGLAYPSISSSGATPVFPNIWNQGLVSQ.DLFSVYL 
PEPC S—OACTSHSRFNPSESSTYSTNGQTFSLCjYGSGSLTGFFGYPTLTV QSIQVPNQEFGLSENEPGTNFVYAQFDGIMGLAYPALSVDEATTAMQGMVQEGALTSPVFSVYL 
CHYM S—NACKNHQRFPPRKSSTFQNLGKPLSIHYGTGSMQGILGYPTVTV SNIVPIQQTVGLSTQEPGPVFTYAEFPGILGMAYPSLASEYSIPVFPNMMNRHLVAQPLFSVYM 
KAP NRDSEGSDGGEL·VLGGSDPAHYVPPL·TFIPVTIPAYWQVHMESVKVGTGL·S 
CATD NRPPEGQPGGELMLGGTDSKYYHGELSYLNVTRKAYWQVHMDQLEVGNELT-: 
CATE SSNPEGGAGSELIFGGYDHSHFSGSLNWVPVTKQAYMQIALDNIQVGGTVM-: 
R E N l NR-GSHLLGGEWLGGSDPQHYQGNFHYVSISKTDSWQITMKGVSVGSSTL-: 
PEPA S—ADDQSGSWIFGGIDSSYYTGSLNWVPVTVEGYWQITVDSITMNGEAI 
PEPC SN-QQGSSGGAWFGGVDSSLYTGQIYWAPVTQELYMQIGIEEFLIGGQASGWCSEGCQJ(IVDTGTS|LLTVPQQYMSAI.LQATGAQEDEYGQFLVNCNSIQNLPSLTFIINGVEFPLPPS 
CHYM D — Ρ Ν Ο Ο Ε - ε Μ Ε Τ Ε 6 Α Ι Ρ Ρ 5 Υ Υ Τ α 5 Ε Η ν > ν Ρ ν Τ ν ς θ Υ Μ Ο Ρ Τ ν Ρ Β ν Τ Ι Β θ ν ν ν - Α ΰ Ε 6 6 ΰ θ 4 ΐ ί Ρ Τ α Τ 5 | κ Ε ν θ Ρ 3 3 Ρ Ι ί Ν Ι Ο Ο Α Ι 6 Α Τ Ο Ν Ο Υ Ο Ε Γ Ρ Ι Ρ ΰ Ρ ΐ η ι 5 Υ Μ Ρ Τ ν ν Γ Ε Ι Ν α Κ Μ Υ Ρ ί Τ Ρ 5 
■LCAQGCSi ILDTGTSLITGPSEEIFJU^NKAIGGYPFLNGQYFIQCSKTPTLPPVSFHLGGVWFNLTGQ. 
■LCKGGCEiIVPTGTSLLVGPVEEVKELQKAIGAVPLIQGEYMIPCEKVSSLPTVYLKLGGKNYELHPD 
•CQP. I V P T G T S LITGPSDKIKQLQNAIGAAP-VDGEYAVECANLNVMPDVTFTINGVPYTLSPT 
L C E E G C A \ , W P T G S S F I S A P T S S L K L I M Q A L G A K E K R I E E Y W N C S Q V P T L P P I S F P L G G R A Y T L S S T 
A C A E G C Q i I V P T G T £ L L T G P T S P I A N I Q S P I G A S E N S D G D M W S C S A I S S L P P I V F T I N G V O . Y P V P P S 
KAP DYVIKILQSPVGLCLLGFQALDIPKPAG-PLWILGDVFLGPYVAVFDRGDKNVGPRVGLARAQSRSTPRAERRTTQAQFFKRRPG 
CATP K Y I L K V S O G G K T I C L S G F M G M P I P P P S G - P L W I L G P V F I G S Y Y T V F P R P N N RVGFANAWL 
CATE AYTLLPFVPGMQFCSSGFQGLPIHPPAG-PLWILGDVFIRQFYSVFPRGNN RVGLAPAVP 
R E N l PYVLQYP|yyy?KLCTLAI,HAMDIPPPTG-PVWVLGATFIRKFYTEFPRHNN RIGFALAR 
PEPA A Y I L Q S E GSCISGFQGMNLPTESGE-LWILGDVFIRQYFTVFPRANN QVGLAPVA 
PEPC S Y I L S N N GYCTVGVEPTYLSSQNGQPLWILGPVFLRSYYSVYDLGNN RVGFATAA 
CHYM AYTSQPQ GFCTSGFQSENHSQK WILGPVFIREYYSVFPRANN LVGLAKAI 
* * * * * * * * * 
Fig. 2. Amino acid sequence comparison among mammalian aspartic proteases. Alignment of amino acid sequences of mouse kidney-derived 
aspartic protease-like protein (KAP) with those of mouse cathepsin D (CATD), human cathepsin E (CATE), mouse renal renin (REN1), hu-
man pepsin A (PEPA), human gastricsin (PEPC), and bovine chymosin (CHYM). Signal sequence and pro-peptide are shown in lower case 
and italic letters, respectively. Gaps are introduced for maximal alignment. Identical amino acids are indicated by asterisks. Conserved amino 
acid residues around active sites are boxed. An insertional sequence specific for cathepsin D is underlined. A 4-residue addition in renin con-
taining the proteolytic processing site is double underlined. Amino acid sequences of CATD, CATE, RENl, PEPA, PEPC, and CHYM are 
from SWISS-PROT database accession number P18242, P14091, P06281, P00790, P20142, and P00794, respectively. 
signal sequence, were in the same positions as those of other 
six aspartic proteases. These findings suggest that their three-
dimensional structures and functions are closely related [14]. 
However, KAP is unique among aspartic proteases to have a 
longer C-terminus. 
Aspartic proteases are known to be produced as proen-
zymes and the N-terminal pro-peptides are released upon ac-
tivation [1,2]. KAP may also be produced as a proenzyme, but 
its cleavage site has yet to be determined. Cathepsin D exists 
as single-chain or two-chain enzyme in vivo [16], and the 
proteolytic processing of the single-chain to two-chain form 
takes place among an insertional sequence specific for cathep-
sin D (Fig. 2, underlined). However, KAP lacked this inser-
tion, suggesting that it exists as single-chain enzyme like other 
aspartic proteases. A 4-residue addition in KAP at position 
343-346 (Fig. 2, Gln-Ser-Asp-Val) was shared by cathepsin 
D, cathepsin E, and renin, which is the site for proteolytic 
processing for single-chain renin [16]. The known processing 
recognition Arg-Arg sequence in renin was changed to Ser-
Asp in KAP, suggesting that KAP is not cleaved at this re-
gion. 
mRNA level [17,18], suggesting the importance of KAP in the 
kidney. 
3.5. In situ hybridization analysis of KAP mRNA in the kidney 
Fig. 4 depicts in situ hybridization analysis of mouse KAP 
mRNA expression in the kidney using 35S-CTP-labeled cRNA 
3.4. Northern blot analysis 
Northern blot analysis with the mouse KAP cDNA probe 
identified a 1.6 kb single hybridizing band found most abun-
dantly in the kidney (Fig. 3). The mRNA was also expressed 
at a moderate level in the lung and at low levels in the spleen 
and adipose tissue. No significant amounts of mRNA were 
detected in other tissues. The restricted distribution of the 
KAP mRNA expression is in good contrast with the ubiquit-
ous distribution of cathepsin D mRNA expression [1,2,17]. 
The KAP mRNA level in the kidney is as high as the cathep-
sin D mRNA level, and much higher than the cathepsin E 
Fig. 3. Northern blot analysis of mouse KAP mRNA expression in 
tissues. Fifty micrograms of total RNA were loaded in each lane. 
The 28S ribosomal RNA bands visualized with ethidium bromide 
are shown in the bottom panel to verify the equivalent loading of 
RNA. 
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Fig. 4. In situ hybridization analysis of mouse KAP mRNA expression in the kidney. Ten micrometer sections were probed with 35S-CTP-la-
beled mouse KAP cRNA. A: Autoradiograph by the antisense probe, showing the overall distribution of the mRNA expression. B: Control 
experiment by the sense probe. C,D: Bright-field photomicrographs (Magnifications: C, XlOO; D, X200). Intense autoradiographic grains for 
KAP mRNA were restricted to the proximal straight tubule (arrow in C), and faint grains were to the proximal convoluted tubule (arrow in 
D), whereas no significant signals were observed in the glomerulus (arrowhead in D). 
probe. At autoradiograph, strong hybridization signals were 
observed in the outer stripe of the outer medulla, and weak 
signals radiated toward the cortex (Fig. 4A). Little back-
ground signals were seen in sections hybridized with the sense 
c R N A probe (Fig. 4B). At photomicrograph, the intense la-
beling in the outer stripe was confined to the proximal straight 
tubule (Fig. 4C), which was confirmed by periodic acid Schiff 
reaction for staining of the brush border membrane (data not 
shown). The weak labeling in the cortex was detected in the 
proximal convoluted tubule, whereas no significant signals 
were found in the glomerulus (Fig. 4D). Previous immunohis-
tochemical studies have revealed the intra-renal localizations 
of various proteases in rats [19-21]; cathepsin D is present 
most abundantly in the cortical collecting tubule, and cathep-
sin B and H (cysteine proteases) are mainly in the proximal 
convoluted tubule (SI segment). The characteristic distribu-
tion of K A P suggests that K A P plays different roles from 
those of known proteases produced in the kidney. 
3.6. Conclusion 
In conclusion, we isolated a c D N A encoding a novel aspar-
tic protease-like protein from the mouse kidney. The present 
study will lead to the better understanding of the mechanisms 
underlying the physiologic function of the kidney. 
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